Patients with COVID-19 pneumonia
From a total of 25 patients who were prescribed to perform spiral chest
CT-scan, 13 showed non-severe and severe COVID-19 pneumonia. On the late
echocardiogram, LVSVI and LVEF showed significant rise (21.3±4.1 vs.
29.1±5.5, p-value=0.03 and 57.5 [53.3-64.4] vs. 64 [59.5-66.1],
p-value=0.01, respectively) in comparison with the baseline
echocardiogram. There was an increase, though not statistically
significant, in LVGLS (-20.3% [-22.1- -18.8] vs. -23.2% [-24.3-
-20.6], p-value=0.08) and LVGCS (-27.9% ±3.6 vs. -30.2% ±4.3,
p-value=0.34) over the study time frame. Amongst RV echocardiographic
indices, RVFAC and TAPSE showed a decrease which was not statistically
significant (48.7 % [42.7-52] vs. 36.55 % [30.7-49.5],
p-value=0.059 and 23 mm [21.5-25] vs. 22 mm [21-25],
p-value=0.96, respectively). Also, none of the other indices changed
significantly, including RVEDVI, RVESVI, RVEF, RVFAC, RVsm, and RV
strain rate. Of LA parameters consisting of LA peak SR and LAESV, none
showed a statistically significant change on the late echocardiogram. RA
parameters, including systolic PAP and peak SR, did not demonstrate any
significant change over the follow-up time. (Supplementary Table S2)